Actively Recruiting

Phase Not Applicable
Age: 30Years - 60Years
FEMALE
Healthy Volunteers
NCT07275333

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

Led by Karolinska Institutet · Updated on 2025-12-18

1000

Participants Needed

1

Research Sites

73 weeks

Total Duration

On this page

Sponsors

K

Karolinska Institutet

Lead Sponsor

U

Union for International Cancer Control

Collaborating Sponsor

AI-Summary

What this Trial Is About

In 2020, a cervical screening center was established in Zaporizhzhia (Ukraine), initiating a pilot project to evaluate the prevalence of HPV among women in Eastern Ukraine. The findings were intended to lay the groundwork for the Ukrainian Ministry of Health in establishing a structured national screening program. However, all efforts were halted due to the nearby armed conflict, situated just 40 kilometers from the border. The World Health Organization's goal to eliminate cervical cancer globally has a gap when it comes to managing cancer control during crises like armed conflicts. We propose a demonstration project to assess whether a simpler, yet modern, cervical cancer control strategy (based on using self-sampling for HPV detection) could also be effective for cervical cancer screening in Zaporizhzhia. Women aged 30-60 years who have not had a recent negative HPV test will be invited to participate. Participants receive a self-sampling kit from their primary care provider and can return the sample free of charge to the clinic or community volunteers. All samples are analyzed in accredited laboratories in Zaporizhzhia. HPV-positive women will receive follow-up care according to national guidelines, including referral to gynecologists for additional tests and treatment if needed. HPV-negative women will be reassured and advised on future screening intervals. The study also evaluates how well the screening program can be implemented during conflict conditions. This includes measuring women's acceptance of self-sampling, the willingness of providers to adopt the procedures, and whether the screening process is feasible, practical, and sustainable. Additional process evaluation will explore how the program adapts to challenges such as migration, disrupted health services, and safety concerns. This project is conducted through collaboration between Zaporizhzhia State Medical and Pharmaceutical University, the Charitable Foundation "World Against Cancer," and Karolinska Institutet in Sweden, which provides quality assurance support for laboratory procedures. The goal is to establish a safe, effective, and sustainable cervical cancer screening model that can be used in conflict-affected regions and similar settings. This work is supported by a grant from the Union for International Cancer Control (UICC), as part of the Reimagining Cancer Research in Europe Initiative.

CONDITIONS

Official Title

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

Who Can Participate

Age: 30Years - 60Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 30-60 years
  • Intact uterus (no prior hysterectomy)
  • Eligible for cervical cancer screening according to local guidelines
  • Able to provide informed consent
  • Able to perform self-sampling at home or at a clinic
Not Eligible

You will not qualify if you...

  • History of total hysterectomy
  • Pregnancy at the time of enrollment
  • Known diagnosis of cervical cancer
  • Inability or unwillingness to provide informed consent
  • Unable to perform self-sampling or comply with study procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Educational and Scientific Medical Center "Universitetskaya Klinika", Zaporizhzhia State Medical and Pharmaceutical University

Zaporizhzhya, Ukraine, 69000

Actively Recruiting

Loading map...

Research Team

L

Laila Sara Arroyo Mühr, PhD

CONTACT

J

Joakim Dillner, Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here